EFM
PRME icon

E Fund Management’s Prime Medicine PRME Stock Holding History

E Fund Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.3K Buy
+27,099
New +$103K ﹤0.01% 472

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

E Fund Management's PRME Position: Q1 2026 in Review

E Fund Management opened a new position in Prime Medicine (PRME) in Q1 2026: 27,099 shares worth $94.3K. The stake represents ﹤0.01% of the portfolio and ranks #472 among its holdings.

192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • E Fund Management held 27,099 shares of Prime Medicine worth $94.3K as of Q1 2026.
  • Prime Medicine was a new E Fund Management position in Q1 2026.
  • Prime Medicine made up ﹤0.01% of E Fund Management's portfolio in Q1 2026, its #472 holding.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.